A Phase I Study Of Oral Irinotecan, Temozolomide, Cefixime In Children With Recurrent/Resistant High-Risk Neuroblastoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cefixime; Irinotecan; Temozolomide
- Indications Neuroblastoma
- Focus Adverse reactions
- 15 Oct 2010 Biomarkers information updated
- 02 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Aug 2006 Status change